Monashee Investment Management »

Zenas Biopharma shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.5M 150k 16.92

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Casella Waste Sys Cl A (CWST)
Aercap Holdings Nv SHS (AER)
Viking Holdings Ord Shs (VIK)
American Healthcare Reit Com Shs (AHR)
Lineage
Sable Offshore Corp Com Shs (SOC)
Newmont Mining Corporation (NEM)

View all positions for Monashee Investment Management

Top funds holding Zenas Biopharma

NEA Management Company
Fairmount Funds Management
NVP Associates
Deerfield Management Company
Federated Investors
Novo A/S
Perceptive Advisors
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Arrowpoint Asset Management
Monashee Investment Management
Citadel Advisors
Standard Life Aberdeen
Point72 Asset Management
Soros Fund Management

View all funds holding Zenas Biopharma